Satiogen Pharmaceuticals is Pharmaceuticals in United States that focus on postprandial glucose business. Founded in 2007. They cover business area such as metabolic mechanism therapy, postprandial glucose, a substitute, metformin, gliptin formulation, an OTC nutraceutical, body weight, doctor, obesity, intervention.
2007
( 17 years old in 2024 )
Postprandial Glucose
-
350 10th Avenue
Suite 820
San Diego, CA 92101
United States
Private
metabolic mechanism therapypostprandial glucosea substitutemetformingliptin formulationan OTC nutraceuticalbody weightdoctorobesityintervention
* We use standard office opening hours in near Satiogen Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Satiogen Pharmaceuticals is Pharmaceuticals business from United States that founded in 2007 (17 years old in 2024), Satiogen Pharmaceuticals business is focusing on Postprandial Glucose.
Satiogen Pharmaceuticals headquarter office and corporate office address is located in 350 10th Avenue Suite 820 San Diego, CA 92101 United States.
Satiogen Pharmaceuticals was founded in United States.
In 2024, Satiogen Pharmaceuticals is currently focus on postprandial glucose sector.
Above is snippet of Google Trends for "postprandial glucose" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Satiogen Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
